Our locations are open for all appointments and procedures, including COVID-19 testing. Schedule an appointment online or call your doctor’s office. Patients may now be accompanied by visitors. Read our updated visitor policy.

Skip to main content
NYU Langone Provider

William M. Gerba, MD

NYU Langone Provider
  • Specialty: Pediatric Hematology-Oncology
  • Language: English
  • Phone: 516-663-9400
View Locations

Conditions and Treatments

Conditions
  • lymphadenopathy
  • neutropenia
  • thalassemia
  • lymphoma
  • anemia
  • sickle cell anemia
  • leukemia
  • thrombosis
  • brain tumor

Positions
  • Clinical Assistant Professor, Department of Pediatrics at NYU Long Island School of Medicine
Board Certifications
  • American Board of Pediatrics - Pediatrics, 2009
  • American Board of Pediatrics (Pediatric Hematology-Oncology), 1980
Education and Training
  • Fellowship, New York Weill Cornell Med Ctr, Pediatric Hem/onc, 1980
  • Residency, Montefiore Medical Center, Pediatric Hem/onc, 1977

Is this your profile?

Edit profile

This provider accepts the following insurance plans.

  • Aetna
    • Aetna HMO
    • Aetna Indemnity
    • Aetna Medicare
    • Aetna POS
    • Aetna PPO/EPO
  • Cigna
    • Cigna EPO/POS
    • Cigna PPO
  • Empire Blue Cross Blue Shield
    • Empire Blue Cross Blue Shield HealthPlus
    • Empire Blue Cross Blue Shield HealthPlus Essential
  • Fidelis
    • Fidelis Child Health
    • Fidelis Essential
    • Fidelis Exchange
    • Fidelis Medicaid
    • Fidelis Medicare
  • GHI
    • GHI CBP
    • GHI HMO
  • HIP
    • HIP Access I
    • HIP Essential
    • HIP Medicaid
  • HealthSmart
    • HealthSmart (WTC)
View All Accepted Plans This list of insurances changes regularly, and insurance plans listed may not be accepted at all office locations for this provider. Before your appointment, please confirm with your insurance company that this provider accepts your insurance.

Locations and Appointments

Winthrop Pediatric Associates - Mineola

120 Mineola Boulevard, Suite 460
Mineola, NY 11501

  • A Phase 3 Randomized Non-Inferiority Study of Carboplatin and Vincristine versus Selumetinib (NSC# 748727 IND# 77782) in Newly Diagnosed or Previously Untreated Low-Grade Glioma (LGG) not associated with BRAFV600E Mutations or Systemic Neurofibromatosis Type 1(NF1)

    Learn More
  • Phase 2 Trial of XL184 (Cabozantinib) an Oral Small-Molecule Inhibitor of Multiple Kinases in Children and Young Adults with Refractory Sarcomas Wilms Tumor and Other Rare Tumors

    Learn More
  • Phase 3 Accelerated BEP Trial: A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours

    Learn More
View All Research Studies (7)